Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease

As a result of increased prevalence of obesity worldwide, non-alcoholic fatty liver disease (NAFLD) has become one of the most common causes of chronic liver disease. Although most NAFLD cases remain benign, some progress to end-stage liver diseases such as cirrhosis and hepatocellular carcinoma. Th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Chronic Dis Transl Med
Prif Awduron: Jiang, Yong, Han, Tao, Zhang, Zhi-Guang, Li, Man, Qi, Feng-Xiang, Zhang, Ying, Ji, Ying-Lan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: KeAi Publishing 2017
Pynciau:
Perspective
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643779/
https://ncbi.nlm.nih.gov/pubmed/29063072
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cdtm.2017.06.003
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg